Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hart

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2003
Large animal models: bridging the gapStephen L Hart
Current Drug Delivery|November 25, 2005
Lipid carriers for gene therapyStephen L Hart
Cell Biology and Toxicology|February 4, 2010
Multifunctional nanocomplexes for gene transfer and gene therapyStephen L Hart
Nanomedicine : Nanotechnology, Biology, and Medicine|August 17, 2010
Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA deliveryAlbert Kwok, Stephen L Hart
Current Opinion in Pharmacology|November 7, 2017
Genetic therapies for cystic fibrosis lung diseaseStephen L Hart, Patrick T Harrison
Phytotherapy Research : PTR|August 8, 2002
Coleonema album: studies of the pharmacological action on smooth muscle in vitro and antimicrobial action of its essential oilMaria Lis-Balchin, Stephen L Hart
International Journal of Pharmaceutics|November 4, 2020
Assembly strategy of liposome and polymer systems for siRNA deliveryHuiling Song, Stephen L Hart, Zixiu Du
Scientific Reports|January 25, 2020
Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cellsJinhong Meng, Aristides D Tagalakis, Stephen L Hart
Nucleic Acid Therapeutics|April 3, 2020
<i>MYCN</i> Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic AcidRuhina Maeshima, Dale Moulding, Andrew W Stoker, et al.
Chemical Biology & Drug Design|December 20, 2015
Systematic Comparisons of Formulations of Linear Oligolysine Peptides with siRNA and Plasmid DNAAlbert Kwok, David McCarthy, Stephen L Hart, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2003
Large animal models: bridging the gapStephen L Hart
Current Drug Delivery|November 25, 2005
Lipid carriers for gene therapyStephen L Hart
Cell Biology and Toxicology|February 4, 2010
Multifunctional nanocomplexes for gene transfer and gene therapyStephen L Hart
Nanomedicine : Nanotechnology, Biology, and Medicine|August 17, 2010
Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA deliveryAlbert Kwok, Stephen L Hart
Current Opinion in Pharmacology|November 7, 2017
Genetic therapies for cystic fibrosis lung diseaseStephen L Hart, Patrick T Harrison
Phytotherapy Research : PTR|August 8, 2002
Coleonema album: studies of the pharmacological action on smooth muscle in vitro and antimicrobial action of its essential oilMaria Lis-Balchin, Stephen L Hart
International Journal of Pharmaceutics|November 4, 2020
Assembly strategy of liposome and polymer systems for siRNA deliveryHuiling Song, Stephen L Hart, Zixiu Du
Scientific Reports|January 25, 2020
Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cellsJinhong Meng, Aristides D Tagalakis, Stephen L Hart
Nucleic Acid Therapeutics|April 3, 2020
<i>MYCN</i> Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic AcidRuhina Maeshima, Dale Moulding, Andrew W Stoker, et al.
Chemical Biology & Drug Design|December 20, 2015
Systematic Comparisons of Formulations of Linear Oligolysine Peptides with siRNA and Plasmid DNAAlbert Kwok, David McCarthy, Stephen L Hart, et al.
Pageof 8